EP1393734A4 - Medicaments pour les maladies intestinales - Google Patents
Medicaments pour les maladies intestinalesInfo
- Publication number
- EP1393734A4 EP1393734A4 EP02728122A EP02728122A EP1393734A4 EP 1393734 A4 EP1393734 A4 EP 1393734A4 EP 02728122 A EP02728122 A EP 02728122A EP 02728122 A EP02728122 A EP 02728122A EP 1393734 A4 EP1393734 A4 EP 1393734A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- intestinal diseases
- drugs
- ameliorating
- preventing
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000028774 intestinal disease Diseases 0.000 title abstract 5
- 239000003814 drug Substances 0.000 title abstract 4
- 229940079593 drug Drugs 0.000 title abstract 4
- 229920001503 Glucan Polymers 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 235000013402 health food Nutrition 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001166982 | 2001-06-01 | ||
JP2001166982 | 2001-06-01 | ||
PCT/JP2002/004980 WO2002098433A1 (fr) | 2001-06-01 | 2002-05-23 | Medicaments pour les maladies intestinales |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1393734A1 EP1393734A1 (fr) | 2004-03-03 |
EP1393734A4 true EP1393734A4 (fr) | 2006-04-12 |
Family
ID=19009439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02728122A Withdrawn EP1393734A4 (fr) | 2001-06-01 | 2002-05-23 | Medicaments pour les maladies intestinales |
Country Status (4)
Country | Link |
---|---|
US (2) | US20040138172A1 (fr) |
EP (1) | EP1393734A4 (fr) |
JP (1) | JP4238726B2 (fr) |
WO (1) | WO2002098433A1 (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002098440A1 (fr) * | 2001-06-01 | 2002-12-12 | Ajinomoto Co., Inc. | Traitement antidiabetique |
NO20014256D0 (no) | 2001-09-03 | 2001-09-03 | Bjoern Kristiansen | Fremstilling av immunstimulerende forbindelse |
GB0225502D0 (en) * | 2002-11-01 | 2002-12-11 | Zoolife Internat Ltd | Therapeutic and prophylactic preparations |
CA2847517A1 (fr) | 2004-02-04 | 2005-08-18 | Pharmaaware Sepsis B.V. | Utilisation de phosphatase alcaline pour la desintoxication du lps |
US7514085B2 (en) * | 2004-07-16 | 2009-04-07 | Medimush A/S | Immune modulating compounds from fungi |
DE602006009144D1 (de) | 2005-11-21 | 2009-10-22 | Bioatlantis Ltd | Zusammensetzungen für die verbesserung der darmgesundheit und der tierischen leistung enthaltend beta-glucans and alfa-fucans |
CN101360508B (zh) * | 2006-01-20 | 2012-09-05 | 森永乳业株式会社 | 用于肠道疾病的药物组合物、饮食品或饲料 |
JP2007204717A (ja) * | 2006-02-06 | 2007-08-16 | Nagaoka Univ Of Technology | きのこ由来の多糖類取得方法 |
JP2011503161A (ja) * | 2007-11-13 | 2011-01-27 | バイオテック・ファルマコン・アーエスアー | 腸管の炎症性疾患を処置または予防する方法 |
AU2009227183A1 (en) * | 2008-03-18 | 2009-09-24 | Amino Up Chemical Co., Ltd. | Enteral nutrient |
WO2012001347A1 (fr) * | 2010-06-29 | 2012-01-05 | Ucl Business Plc | Produits à effets bénéfiques sur la santé bucco-dentaire |
JP5928774B2 (ja) * | 2011-11-01 | 2016-06-01 | 株式会社大阪ソーダ | β−1,3−グルカンを含む過敏性腸症候群の下痢抑制剤、腹痛改善剤、及び大腸における痛覚過敏改善剤 |
WO2014136982A1 (fr) * | 2013-03-08 | 2014-09-12 | 学校法人東京理科大学 | Promoteur de prolifération de lactobacille, agent de prolifération de cellules t régulatrices, procédé favorisant la prolifération de lactobacille, procédé de prolifération de cellules t régulatrices, procédé d'évaluation de l'efficacité de la prolifération de cellules t régulatrices, et procédé d'évaluation de l'efficacité de la promotion de la prolifération de lactobacille |
JP6713147B2 (ja) | 2014-01-24 | 2020-06-24 | アーエム−ファルマ ベー.フェー.AM−Pharma B.V. | アルカリホスファターゼの下流プロセシング |
JP6940949B2 (ja) | 2014-01-24 | 2021-09-29 | アーエム−ファルマ ベー.フェー.AM−Pharma B.V. | キメラアルカリホスファターゼ様タンパク質 |
CN116440154A (zh) * | 2015-10-28 | 2023-07-18 | 凯敏工业公司 | 用于调节免疫功能和治疗肠道炎症的组合物 |
CN110638803A (zh) * | 2019-10-24 | 2020-01-03 | 上海长海医院 | Dencichine在制备治疗炎性肠病药物中的用途 |
WO2023002252A1 (fr) | 2021-07-21 | 2023-01-26 | Bioatlantis Limited | Composition comprenant des bêta-glucanes et des alpha-fucanes pour amélioration de la santé intestinale et des performances animales et leurs procédés de fabrication |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000041541A2 (fr) * | 1999-01-12 | 2000-07-20 | Vito-Mannan Polysaccharide L.L.C. | Procede servant a isoler des polysaccharides mucilagineux et leurs utilisations |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62163685A (ja) * | 1986-01-14 | 1987-07-20 | Dainippon Ink & Chem Inc | ビフイドバクテリウム菌増殖促進組成物及びその製造法 |
JP4091137B2 (ja) * | 1997-01-17 | 2008-05-28 | キリンフードテック株式会社 | 免疫抑制剤 |
JP2000178302A (ja) * | 1998-12-14 | 2000-06-27 | Nippon Mitsubishi Oil Corp | 動物用ワクチン効果増強剤 |
US6737089B2 (en) * | 1999-08-27 | 2004-05-18 | Morinda, Inc. | Morinda citrifolia (Noni) enhanced animal food product |
WO2002098440A1 (fr) * | 2001-06-01 | 2002-12-12 | Ajinomoto Co., Inc. | Traitement antidiabetique |
-
2002
- 2002-05-23 WO PCT/JP2002/004980 patent/WO2002098433A1/fr active Application Filing
- 2002-05-23 EP EP02728122A patent/EP1393734A4/fr not_active Withdrawn
- 2002-05-23 JP JP2003501472A patent/JP4238726B2/ja not_active Expired - Fee Related
-
2003
- 2003-11-25 US US10/720,169 patent/US20040138172A1/en not_active Abandoned
-
2006
- 2006-04-04 US US11/278,585 patent/US20060159698A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000041541A2 (fr) * | 1999-01-12 | 2000-07-20 | Vito-Mannan Polysaccharide L.L.C. | Procede servant a isoler des polysaccharides mucilagineux et leurs utilisations |
Non-Patent Citations (6)
Title |
---|
BOBEK P; NOSALOVA V; CERNA S: "Effect of pleuran (beta-glucan from Pleurotus ostreatus) in diet or drinking fluid on colitis in rats", NAHRUNG, vol. 45, no. 5, October 2001 (2001-10-01), pages 360 - 363, XP002367630 * |
BOHN J A ET AL: "(1-3)-beta-d-Glucans as biological response modifiers: a review of structure-functional activity relationships", CARBOHYDRATE POLYMERS, APPLIED SCIENCE PUBLISHERS, LTD. BARKING, GB, vol. 28, no. 1, 1995, pages 3 - 14, XP004034425, ISSN: 0144-8617 * |
KARACSONYI S ET AL: "POLYSACCHARIDES OF PLEUROTUS OSTREATUS: ISOLATION AND STRUCTURE OF PLEURAN, AN ALKALI-INSOLUBLE BETA-D-GLUCAN", CARBOHYDRATE POLYMERS, APPLIED SCIENCE PUBLISHERS, LTD. BARKING, GB, vol. 24, no. 2, 1994, pages 107 - 111, XP001053703, ISSN: 0144-8617 * |
NOSALOVA V, CERNA S, BOBEK P, GALBAVY S, KUNIAK L: "The effects of pleuran upon parameters of colonic inflammation in rats", CESKOSLOVENSKA FYSIOLOGIE, vol. 48, 1999, pages 157, XP008059917 * |
NOSALOVA V; BOBEK P; CERNA S; GALBAVY S; STVRTINA S: "Effects of pleuran (beta-glucan isolated from Pleurotus ostreatus) on experimental colitis in rats", PHYSIOLOGICAL RESEARCH, vol. 50, no. 6, December 2001 (2001-12-01), pages 575 - 581, XP002367629 * |
YOSHIOKA Y ET AL: "ANTITUMOR POLYSACCHARIDES FROM P. OSTREATUS (FR.) QUEL.: ISOLATION AND STRUCTURE OF A BETA-GLUCAN", CARBOHYDRATE RESEARCH, ELSEVIER SCIENTIFIC PUBLISHING COMPANY. AMSTERDAM, NL, vol. 140, 1985, pages 93 - 100, XP001053561, ISSN: 0008-6215 * |
Also Published As
Publication number | Publication date |
---|---|
JPWO2002098433A1 (ja) | 2004-09-16 |
JP4238726B2 (ja) | 2009-03-18 |
US20060159698A1 (en) | 2006-07-20 |
WO2002098433A1 (fr) | 2002-12-12 |
EP1393734A1 (fr) | 2004-03-03 |
US20040138172A1 (en) | 2004-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1393734A4 (fr) | Medicaments pour les maladies intestinales | |
CA2431565A1 (fr) | Nouvelles compositions pharmaceutiques a base d'anticholinergiques et de ciclesonide | |
WO2004112711A3 (fr) | Composition orale a liberation prolongee | |
WO2001027109A3 (fr) | Derives de tert.-butyl-(methyl-imidazo[1,2-a]pyridine-3-yl)amine | |
EP2255815A3 (fr) | Composition nutritive | |
WO2005046640A3 (fr) | Plateforme d'administration de medicaments a sites multiples | |
WO2001090091A8 (fr) | Inhibiteurs de 11-beta-hydroxy-steroide-deshydrogenase de type 1 | |
CA2350713A1 (fr) | Utilisation de substances biochimiques pour obtenir une composition pour la prevention et le traitement de conditions physiques causees par la constriction de cellules musculaireslisses dans les organes du corps humain | |
HUP0300218A2 (hu) | Eljárás diabetes kezelésére, metformin és glybarid kombinációját alkalmazva | |
WO2002088100A3 (fr) | 3-piperidinopropiophenones dopees et produits pharmaceutiques contenant ces composes | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
WO2002087596A3 (fr) | Nouvelle indication therapeutique d'azithromycine pour le traitement des maladies inflammatoires non infectieuses | |
CA2412789A1 (fr) | Compositions destinees a ameliorer la concentration mentale | |
EP1393738A4 (fr) | Traitement antidiabetique | |
CA2180178A1 (fr) | Utilisation des derives 2,3-diaryl-1-benzopyrane dans la production d'un medicament employe dans le traitement et la prevention de la diminution du volume du tissu osseux et de l'osteoporose | |
HUP0302538A3 (en) | 3,7-diazabicyclo[3.3.0]oczanes and their use in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them | |
WO2001028526A3 (fr) | Comprimes gastroresistants a usage alimentaire, dietetique et therapeutique | |
IT1314199B1 (it) | Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita' | |
WO2003002125A3 (fr) | Combinaison de sucres amines et cysteine ou de derives de cysteine | |
BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
CA2396209A1 (fr) | Utilisation de mirtazapine pour traiter des troubles du sommeil | |
MXPA02011533A (es) | Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona. | |
CA2474430A1 (fr) | Polytherapie combinant un agent thrombolytique et du levosimendane pour le traitement de l'infractus aigu du myocarde | |
HK1075654A1 (en) | Hyperforin derivatives, the use thereof and formulations containing them | |
WO2004030684A3 (fr) | Produit de kavalactone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20031113 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060228 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 1/06 20060101ALI20060217BHEP Ipc: A61K 31/716 20060101AFI20021213BHEP |
|
17Q | First examination report despatched |
Effective date: 20071026 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100811 |